Lammers Jenna, Reignier Arnaud, Loubersac Sophie, Chaillot Maxime, Freour Thomas
Service de Médecine Et Biologie de La Reproduction, Hôpital Mère Et Enfant, CHU de Nantes, 38 Boulevard Jean Monnet, Nantes, France.
Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, 44000, Nantes, France.
Reprod Sci. 2025 Feb;32(2):495-501. doi: 10.1007/s43032-024-01762-x. Epub 2025 Jan 9.
Vitrification has revolutionized embryo cryopreservation, but represents a significant workload in the IVF lab. We evaluated here an ultrafast blastocyst warming procedure in order to improve workflow while maintaining clinical outcome. We first evaluated the expression of main markers of lineage specification in a subset of blastocysts donated to research warmed with ultrafast protocol. We then performed a prospective pseudo-randomized pilot study comparing blastocyst survival, reexpansion and live birth rates between standard (3 steps, 15 min), and ultrafast warming protocol (1 step, 2 min). Finally, survival, reexpansion and live birth rates (LBR) obtained with ultrafast warming protocol were prospectively collected during 3 months and compared with previous indicators. Immunofluorescence experiments showed that staining and spatial organization of cell fate markers were conserved with ultrafast protocol. Survival, reexpansion and LBR were strictly comparable between standard (n = 47 cycles) and ultrafast (n = 39 cycles) groups in the pilot study (100 vs 100%, 80 vs 76% and 29.8 vs 30.7% in standard and simplified groups respectively). Survival, expansion and LBR obtained with the ultrafast warming protocol over the next 3-month period (321 cycles, 336 embryos) were comparable with those obtained with the standard protocol throughout the 6 months (547 FBT cycles, 578 embryos) preceding shifting protocol (97.6 and 29.6% vs 97.8 and 28.3% respectively, p > 0.05 for both). In conclusion, using an ultrafast blastocyst warming procedure results in similar embryology and clinical outcomes compared with standard protocol, but significantly shortens the technical procedure, ultimately improving the overall lab's workflow.
玻璃化冷冻技术彻底改变了胚胎冷冻保存方式,但在体外受精实验室中却是一项繁重的工作。我们在此评估了一种超快速囊胚解冻程序,旨在在维持临床结果的同时改善工作流程。我们首先评估了用超快速方案解冻后捐赠用于研究的一部分囊胚中谱系特化主要标志物的表达。然后,我们进行了一项前瞻性伪随机试点研究,比较了标准解冻方案(3步,15分钟)和超快速解冻方案(1步,2分钟)之间的囊胚存活率、再扩张率和活产率。最后,前瞻性收集了超快速解冻方案在3个月内获得的存活率、再扩张率和活产率(LBR),并与之前的指标进行比较。免疫荧光实验表明,超快速方案下细胞命运标志物的染色和空间组织得以保留。在试点研究中,标准组(n = 47个周期)和超快速组(n = 39个周期)的存活率、再扩张率和LBR严格可比(标准组和简化组分别为100%对100%、80%对76%和29.8%对30.7%)。在接下来3个月期间(321个周期,336个胚胎)用超快速解冻方案获得的存活率、扩张率和LBR与在改变方案前的6个月内(547个冻融周期,578个胚胎)用标准方案获得的结果相当(分别为97.6%和29.6%对97.8%和28.3%,两者p均>0.05)。总之,与标准方案相比,使用超快速囊胚解冻程序可获得相似的胚胎学和临床结果,但显著缩短了技术操作时间,最终改善了实验室的整体工作流程。